LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...

There’s no shortage of headlines and hypotheticals about the blockbuster drug class of GLP-1s. Stephen Klasko, MD, argues we’re asking the wrong questions about GLP-1s. For health system leaders, the ...

SoWell is unveiling GLP-1 Support System, a three-part supplement system designed specifically for GLP-1 users and their side effects. Alexandra Sowa, board-certified obesity medicine specialist, and ...

Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...

Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while studying adolescents and young women taking GLP-1 medications for a hormonal ...

GLP-1 medications offer potential for obesity and chronic disease management, but high costs limit accessibility for many patients. Employers struggle to cover GLP-1 costs, with PBMs needing to ...

The National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a workshop on September 10, 2024, they brought together diverse perspectives to examine the promising but ...

GLP-1 drugs such as Ozempic and Wegovy may reduce alcohol intake and other addictive behaviours as well as appetite. Researchers think the lateral septum, a brain region involved in reward and memory, ...

Shares of Inspire Medical SystemsINSP crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for weighing on its second-quarter results. Inspire stock plummeted 32.4 ...

Glucagon-like peptide-1 (GLP-1) is an insulinotropic 1,2 incretin derived from preproglucagon (PPG), which was first identified in the intestine 3. Since its discovery in the periphery, the presence ...